Why the study?
Does higher body mass index improve clinical outcomes in patients with prevalent atrial fibrillation?
Does higher body mass index improve clinical outcomes in patients with prevalent atrial fibrillation?
In patients with prevalent atrial fibrillation, higher BMI is associated with a lower risk of mortality and similar rates of thromboembolic events, suggesting an obesity paradox in this population.
Answers are grounded in this paper and cite their sources.
Should not alter weight management in AF; leaves open obesity paradox and requires prospective validation.
OBJECTIVES: This study sought to determine the association between body mass index (BMI) and clinical outcomes among patients with prevalent atrial fibrillation (AF). BACKGROUND: Higher BMI is an independent risk factor for incident AF. However, its impact on management strategies and clinical outcomes among patients with prevalent AF is unclear. METHODS: Patients with AF enrolled in the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry from June 2010 through August 2011 were stratified into BMI-based categories as normal weight, overweight, class I obese, class II obese, and class III obese. Unadjusted and adjusted Cox frailty models were constructed to assess the association of BMI with clinical outcomes over a 2-year follow-up. RESULTS: increase in BMI, the odds of risk-adjusted mortality were 7% lower. In contrast, BMI was not associated with adjusted risk for thromboembolic events and AF progression. CONCLUSIONS: Although AF patients with higher BMI were significantly younger, higher BMI in AF patients was associated with similar or better clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: